chlorpromazine has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 33 studies
Chlorpromazine: The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.
chlorpromazine : A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Parkinsonism is characterized by rest tremor, inflexibility, balance debilitation, slow motion and dementia." | 1.48 | Anticataleptic activity of Zamzam water in chlorpromazine induced animal model of Parkinson disease. ( Ikram, R; Riaz, B; Sikandar, B, 2018) |
| "Catalepsy was assessed by Bar test on day 21 and day 30 at 30, 60, 90 and 120 minutes interval." | 1.43 | Beneficial anti-Parkinson effects of camel milk in Chlorpromazineinduced animal model: Behavioural and histopathological study. ( Khatoon, H; Mirza, T; Najam, R; Sikandar, B, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (78.79) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (6.06) | 29.6817 |
| 2010's | 4 (12.12) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, SS | 2 |
| Ikram, R | 3 |
| Naeem, S | 2 |
| Khatoon, H | 2 |
| Anser, H | 1 |
| Sikander, B | 1 |
| Rao, SS | 1 |
| Riaz, B | 1 |
| Sikandar, B | 2 |
| Najam, R | 1 |
| Mirza, T | 1 |
| Kane, JM | 1 |
| Correll, CU | 1 |
| Harris, DS | 1 |
| Wolkowitz, OM | 1 |
| Reus, VI | 1 |
| Teixeira, AL | 1 |
| Cardoso, F | 1 |
| Maia, DP | 1 |
| Cunningham, MC | 1 |
| BERGOUIGNAN, M | 1 |
| BENTE, D | 1 |
| ITIL, T | 1 |
| MEGGIO, B | 1 |
| CATTANI, F | 1 |
| FREYHAN, FA | 1 |
| NAHUNEK, K | 1 |
| RYBAKOVA, V | 1 |
| KNAUF, HW | 1 |
| CAHAN, RB | 1 |
| PARRISH, DD | 1 |
| GUGGENHEIM, P | 1 |
| COHEN, L | 1 |
| MERIAUX, J | 1 |
| NAVARRANNE, P | 1 |
| STRATAS, NE | 1 |
| PHILLIPS, RD | 1 |
| WALKER, PA | 1 |
| SANDIFER, MG | 1 |
| RAVKIN, IG | 1 |
| NEHLIL, J | 1 |
| BOHACEK, N | 1 |
| HAJNSEK, F | 1 |
| SARTORIUS, N | 1 |
| MACKIEWICZ, J | 1 |
| GERSHON, S | 1 |
| LICHTIGFELD, FJ | 1 |
| NAYRAC, P | 1 |
| ARNOTT, G | 1 |
| MILBLED, G | 1 |
| BARUK, H | 1 |
| LAUNAY, J | 1 |
| GEORGIADES, G | 1 |
| KYRATSOS, C | 1 |
| MICHAILIDES, G | 1 |
| TSINOPOULOS, T | 1 |
| ZSCHUCKE, CF | 1 |
| BOCKNER, S | 1 |
| STERN, J | 1 |
| WARD, AA | 1 |
| HUNTER, R | 1 |
| EARL, CJ | 1 |
| THRONICROFT, S | 1 |
| DESCHAEPDRYVER, A | 1 |
| LAVERTY, R | 1 |
| SHARMAN, DF | 1 |
| HAASE, HJ | 1 |
| POURSINES, Y | 1 |
| ALLIEZ, J | 1 |
| TOGA, M | 1 |
2 reviews available for chlorpromazine and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Past and present progress in the pharmacologic treatment of schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Clozapine; Controlled Clinical Trials as Topic; Diabetes Melli | 2010 |
[PSYCHOPHARMACA: OBSERVATIONS AND INTERPRETATIONS].
Topics: Amphetamine; Amphetamines; Caudate Nucleus; Central Nervous System Stimulants; Chlorpromazine; Dihyd | 1964 |
31 other studies available for chlorpromazine and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Effect of M. chamomilla L. tea on chlorpromazine induced catalepsy: A neuroprotective study.
Topics: Animals; Antiparkinson Agents; Behavior, Animal; Brain; Catalepsy; Chlorpromazine; Disease Models, A | 2020 |
NSAIDs ameliorate cognitive and motor impairment in a model of parkinsonism induced by chlorpromazine.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipsychotic Agents; Behavior, Animal; Chlorproma | 2017 |
Anticataleptic activity of Zamzam water in chlorpromazine induced animal model of Parkinson disease.
Topics: Animals; Brain; Carbidopa; Catalepsy; Chlorpromazine; Disease Models, Animal; Drug Combinations; Hyd | 2018 |
Beneficial anti-Parkinson effects of camel milk in Chlorpromazineinduced animal model: Behavioural and histopathological study.
Topics: Animals; Antiparkinson Agents; Behavior, Animal; Brain; Camelus; Carbidopa; Catalepsy; Chlorpromazin | 2016 |
Movement disorder, memory, psychiatric symptoms and serum DHEA levels in schizophrenic and schizoaffective patients.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Dehydroepiandrosterone; Female; Humans; Hydrocort | 2001 |
Sydenham's chorea may be a risk factor for drug induced parkinsonism.
Topics: Antipsychotic Agents; Chlorpromazine; Chorea; Humans; Parkinsonian Disorders; Retrospective Studies; | 2003 |
[Reversible parkinsonism in the course of largactil therapy of vomiting in pregnancy].
Topics: Chlorpromazine; Female; Parkinson Disease; Parkinsonian Disorders; Pregnancy; Pregnancy Complication | 1954 |
[The effects of high-dosed reserpin (serpasil) treatment and drug-induced parkinsonism-like states on the electroencephalogram].
Topics: Antihypertensive Agents; Chlorpromazine; Electroencephalography; Humans; Parkinson Disease; Parkinso | 1955 |
[Hypothesis on the mechanism of action of chlorpromazine (largactil) on the extrapyramidal manifestations of the parkinsonian syndrome].
Topics: Chlorpromazine; Parkinson Disease; Parkinsonian Disorders | 1955 |
Psychomotility and parkinsonism in treatment with neuroleptic drugs.
Topics: Antipsychotic Agents; Chlorpromazine; Electroconvulsive Therapy; Humans; Mental Disorders; Movement; | 1957 |
[Parkinsonism-like symptoms caused by chlorpromazine therapy].
Topics: Chlorpromazine; Electroconvulsive Therapy; Humans; Parkinson Disease; Parkinsonian Disorders; Psycho | 1958 |
[Treatment of parkinsonism-like syndromes caused by reserpine & chlorpromazine].
Topics: Chlorpromazine; Humans; Parkinson Disease; Parkinsonian Disorders; Piperidines; Reserpine; Syndrome | 1958 |
Reversibility of drug-induced parkinsonism.
Topics: Chlorpromazine; Parkinson Disease; Parkinsonian Disorders; Reserpine | 1960 |
Theoretical considerations in parkinsonism induced by tranquilizing drugs.
Topics: Chlorpromazine; Parkinson Disease; Parkinsonian Disorders; Reserpine; Tranquilizing Agents | 1959 |
[Paradoxical parkinsonian syndrome after drug ingestion in a patient with portacaval anastomosis].
Topics: Chlorpromazine; Parkinson Disease; Parkinsonian Disorders; Portacaval Shunt, Surgical | 1963 |
A study of drug-induced parkinsonism.
Topics: Chlorpromazine; Humans; Mental Disorders; Parkinson Disease; Parkinsonian Disorders; Prochlorperazin | 1963 |
[THE PROBLEM OF ALLERGY IN PSYCHIATRY].
Topics: Chlorpromazine; Drug Hypersensitivity; Epilepsy; Hypersensitivity; Mental Disorders; Parkinsonian Di | 1963 |
[COMPLICATIONS OF NEUROLEPTICS].
Topics: Antipsychotic Agents; Chlorpromazine; Haloperidol; Parkinsonian Disorders; Phenothiazines; Prochlorp | 1963 |
[EXTRAPYRAMIDAL SYMPTOMS DUE TO THE USE OF PSYCHOPHARMACA].
Topics: Chlorpromazine; Chlorprothixene; Extrapyramidal Tracts; Fluphenazine; Imipramine; Methotrimeprazine; | 1963 |
AN EXPERIMENTAL STUDY OF THE NEUROPATHOLOGICAL AND TOXICOLOGICAL EFFECTS OF CHLORPROMAZINE AND RESERPINE.
Topics: Cerebellum; Cerebrovascular Circulation; Chlorpromazine; Guinea Pigs; Nervous System Diseases; Parki | 1964 |
DRUG-INDUCED PARKINSONIAN SYNDROME IN A CASE OF TRANQUILLIZER POISONING.
Topics: Chlorpromazine; Glutethimide; Humans; Muscle Relaxants, Central; Parasympatholytics; Parkinsonian Di | 1964 |
[HUNTINGTON'S CHOREA, HUMOR DISORDERS WITH MANIC MANIFESTATIONS, BENEFICIAL EFFECTS OF HALOPERIDOL (FLUOROPHENYLPIPERIDINOBUTYROPHENONE). ABSENCE OF THE THERAPEUTIC AKINETO-HYPERTONIC SYNDROME].
Topics: Bipolar Disorder; Chlorpromazine; Chorea; Electroencephalography; Electromyography; Haloperidol; Hum | 1964 |
[NEUROLEPTICS AND THE LAW OF STAGES].
Topics: Antipsychotic Agents; Catalepsy; Catatonia; Chlorpromazine; Epilepsy; Humans; Imipramine; Parkinsoni | 1964 |
[OCULAR PRESSURE, NEUROLEPTIC AGENTS AND PARKINSONIAN STATES].
Topics: Antipsychotic Agents; Chlorpromazine; Haloperidol; Intraocular Pressure; Methotrimeprazine; Parkinso | 1963 |
[ON THE ANTAGONISM OF THE ACTION OF NEUROLEPTICS AND ANTIPARKINSON AGENTS].
Topics: Antiparkinson Agents; Antipsychotic Agents; Chlorpromazine; Handwriting; Humans; Movement Disorders; | 1964 |
NEUROLOGICAL SYMPTOMS WITH PHENOTHIAZINES.
Topics: Brain Diseases; Chlorpromazine; Movement Disorders; Neurologic Manifestations; Parkinsonian Disorder | 1964 |
THE RELATIONSHIP OF THE ALPHA AND GAMMA MOTOR SYSTEMS TO THE EFFICACY OF THE SURGICAL THERAPY OF PARKINSONISM.
Topics: Brain; Chlorpromazine; Globus Pallidus; Humans; Movement Disorders; Neurosurgery; Parkinsonian Disor | 1963 |
AN APPARENTLY IRREVERSIBLE SYNDROME OF ABNORMAL MOVEMENTS FOLLOWING PHENOTHIAZINE MEDICATION.
Topics: Brain; Brain Damage, Chronic; Brain Diseases; Chlorpromazine; Chorea; Diagnosis, Differential; Elect | 1964 |
MODIFICATION BY DRUGS OF THE METABOLISM OF 3,4-DIHYDROXYPHENYLETHYLAMINE, NORADRENALINE AND 5-HYDROXYTRYPTAMINE IN THE BRAIN.
Topics: Animals; Atropine; Behavior, Animal; Brain; Brain Chemistry; Cats; Caudate Nucleus; Cerebral Cortex; | 1965 |
[Occurrence and interpretation of psychomotor parkinsonism in megaphen or largactil prolonged therapy].
Topics: Chlorpromazine; Parkinson Disease; Parkinsonian Disorders | 1954 |
[Parkinsonian syndrome following prolonged administration of chlorpromazine with fatal concomitant stroke. Appearance of pallidal lesions].
Topics: Basal Ganglia; Chlorpromazine; Ganglia; Globus Pallidus; Humans; Parkinson Disease; Parkinsonian Dis | 1959 |